Seroatlas · Human Serome Atlas

GBE1

1,4-alpha-glucan-branching enzyme

Also known as: GLGB_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q04446
Gene
GBE1
Ensembl
ENSG00000114480
Chromosome
3
Canonical length
702 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Cytosol

OverviewNCBI Gene

The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

702 residues, UniProt reviewed canonical sequence.

>Q04446|GBE1
     1  MAAPMTPAAR PEDYEAALNA ALADVPELAR LLEIDPYLKP YAVDFQRRYK QFSQILKNIG
    61  ENEGGIDKFS RGYESFGVHR CADGGLYCKE WAPGAEGVFL TGDFNGWNPF SYPYKKLDYG
   121  KWELYIPPKQ NKSVLVPHGS KLKVVITSKS GEILYRISPW AKYVVREGDN VNYDWIHWDP
   181  EHSYEFKHSR PKKPRSLRIY ESHVGISSHE GKVASYKHFT CNVLPRIKGL GYNCIQLMAI
   241  MEHAYYASFG YQITSFFAAS SRYGTPEELQ ELVDTAHSMG IIVLLDVVHS HASKNSADGL
   301  NMFDGTDSCY FHSGPRGTHD LWDSRLFAYS SWEILRFLLS NIRWWLEEYR FDGFRFDGVT
   361  SMLYHHHGVG QGFSGDYSEY FGLQVDEDAL TYLMLANHLV HTLCPDSITI AEDVSGMPAL
   421  CSPISQGGGG FDYRLAMAIP DKWIQLLKEF KDEDWNMGDI VYTLTNRRYL EKCIAYAESH
   481  DQALVGDKSL AFWLMDAEMY TNMSVLTPFT PVIDRGIQLH KMIRLITHGL GGEGYLNFMG
   541  NEFGHPEWLD FPRKGNNESY HYARRQFHLT DDDLLRYKFL NNFDRDMNRL EERYGWLAAP
   601  QAYVSEKHEG NKIIAFERAG LLFIFNFHPS KSYTDYRVGT ALPGKFKIVL DSDAAEYGGH
   661  QRLDHSTDFF SEAFEHNGRP YSLLVYIPSR VALILQNVDL PN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GBE1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.21
Highest tissue expression
142 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 142 nTPM
  • liver: 102 nTPM
  • adipose tissue: 69 nTPM
  • tongue: 53 nTPM
  • heart muscle: 52 nTPM
  • adrenal gland: 51 nTPM

Single-cell type

  • myonuclei: 1,503 nCPM
  • adipocytes: 1,160 nCPM
  • thymic myoid cells: 1,080 nCPM
  • neutrophil progenitors: 887 nCPM
  • neutrophils: 638 nCPM
  • cardiomyocytes: 621 nCPM

Immune cell

  • eosinophil: 16 nTPM
  • myeloid DC: 14 nTPM
  • NK-cell: 14 nTPM
  • naive B-cell: 13 nTPM
  • non-classical monocyte: 12 nTPM
  • classical monocyte: 12 nTPM

Brain region

  • midbrain: 39 nTPM
  • choroid plexus: 29 nTPM
  • medulla oblongata: 21 nTPM
  • pons: 21 nTPM
  • cerebral cortex: 16 nTPM
  • hypothalamus: 16 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GBE1.

Disease | AllUniProt

Conditions GBE1 is implicated in, by any mechanism.

Disease | GeneticClinVar

206 pathogenic / likely-pathogenic of 1,122 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.97
gnomAD pLI
0
gnomAD missense Z
0.09
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GBE1 as an antibody target. Whether an autoantibody or antibody against GBE1 could matter depends on whether native GBE1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GBE1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GBE1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GBE1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...